Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and SurvivalThomas A. Werfel, Craig L. Duvall, Shan Wang et al.|Cancer Research|2018Cited by 82
Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL BlockadeMichelle M. Williams, Rebecca S. Cook, Bushra Rahman et al.|Molecular Cancer Research|2016Cited by 55
Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancersMichelle M. Williams, Rebecca S. Cook, Linus Lee et al.|Cell Death and Disease|2018Cited by 25
Supplementary Figures S1 and S2 from Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL BlockadeMichelle M. Williams, Rebecca S. Cook, Linus Lee et al.|Unknown|2023Cited by 0
Supplementary Figures S3 and S4 from Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL BlockadeMichelle M. Williams, Rebecca S. Cook, Linus Lee et al.|Unknown|2023Cited by 0